Antimicrobial Resistance in Hospital-Acquired Infections: A Study on Pathogen Resistance Patterns
DOI:
https://doi.org/10.70818/jnmc.v02i02.014Keywords:
Antimicrobial Resistance, Hospital-Acquired Infections, Pathogen Resistance Patterns, Multidrug Resistance, Carbapenem ResistanceAbstract
Background: Antimicrobial resistance (AMR) in hospital-acquired infections (HAIs) is a growing concern, impacting patient outcomes and healthcare management globally. The patterns of resistance among pathogens in hospital settings need continuous surveillance to guide treatment. Objective: This study aims to analyze the resistance patterns of pathogens causing hospital-acquired infections in a clinical setting, focusing on their prevalence, mechanisms, and resistance profiles. Methods: A cross-sectional study was conducted at the Department of Microbiology, Netrokona Medical College, from January 2023 to December 2024. The study sample included 144 patients diagnosed with hospital-acquired infections. Pathogen identification and antimicrobial susceptibility testing were carried out using standard microbiological techniques, including the disk diffusion method. Resistance patterns were analyzed for commonly implicated pathogens, including Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Data were statistically analyzed using SPSS version 26, calculating resistance rates, standard deviation, and p-values to assess significance. Results: Of the 144 patients, 82% (n=118) had multidrug-resistant (MDR) infections, with Klebsiella pneumoniae exhibiting the highest resistance at 90.5% against beta-lactams. The average resistance rate for Staphylococcus aureus was 75%, with a notable 68% resistance to methicillin. The mean standard deviation of resistance for all pathogens was 14.7%. Statistical analysis showed a significant association between prolonged hospitalization and resistance (p-value = 0.02). A further breakdown revealed a 12.3% increase in resistance over the study period, indicating the worsening trend. Resistance to carbapenems was observed in 27% of cases, with a significant rise (p-value = 0.03) in ICU patients. Conclusion: The study demonstrates a high prevalence of antimicrobial resistance in hospital-acquired infections, with notable increases in resistance rates over the study period. Enhanced infection control and antibiotic stewardship are critical to combating this threat.
References
1. Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MAA. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare (Basel). 2023 Jul 5;11(13):1946. doi: 10.3390/healthcare11131946. PMID: 37444780; PMCID: PMC10340576.
2. Poudel AN, Zhu S, Cooper N, Little P, Tarrant C, Hickman M, Yao G. The economic burden of antibiotic resistance: A systematic review and meta-analysis. PLoS One. 2023 May 8;18(5):e0285170. doi: 10.1371/journal.pone.0285170. PMID: 37155660; PMCID: PMC10166566.
3. Ayobami O, Brinkwirth S, Eckmanns T, Markwart R. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis. Emerg Microbes Infect. 2022 Dec;11(1):443-451. doi: 10.1080/22221751.2022.2030196. PMID: 35034585; PMCID: PMC8820817.
4. Aslam B, Khurshid M, Arshad MI, Muzammil S, Rasool M, Yasmeen N, Shah T, Chaudhry TH, Rasool MH, Shahid A, Xueshan X, Baloch Z. Antibiotic Resistance: One Health One World Outlook. Front Cell Infect Microbiol. 2021 Nov 25;11:771510. doi: 10.3389/fcimb.2021.771510. Erratum in: Front Cell Infect Microbiol. 2024 Sep 25;14:1488430. doi: 10.3389/fcimb.2024.1488430. PMID: 34900756; PMCID: PMC8656695.
5. Silvester R, Madhavan A, Kokkat A, Parolla A, B M A, M H, Abdulla MH. Global surveillance of antimicrobial resistance and hypervirulence in Klebsiella pneumoniae from LMICs: An in-silico approach. Sci Total Environ. 2022 Jan 1;802:149859. doi: 10.1016/j.scitotenv.2021.149859. PMID: 34464800.
6. Luu T, Albarillo FS. Asymptomatic Bacteriuria: Prevalence, Diagnosis, Management, and Current Antimicrobial Stewardship Implementations. Am J Med. 2022 Aug;135(8):e236-e244. doi: 10.1016/j.amjmed.2022.03.015. PMID: 35367448.
7. Johnson J, Akinboyo IC, Schaffzin JK. Infection Prevention in the Neonatal Intensive Care Unit. Clin Perinatol. 2021 Jun;48(2):413-429. doi: 10.1016/j.clp.2021.03.011. PMID: 34030822; PMCID: PMC8162277.
8. Mojoli F, Bouhemad B, Mongodi S, Lichtenstein D. Lung Ultrasound for Critically Ill Patients. Am J Respir Crit Care Med. 2019 Mar 15;199(6):701-714. doi: 10.1164/rccm.201802-0236CI. Erratum in: Am J Respir Crit Care Med. 2020 Apr 15;201(8):1015. doi: 10.1164/rccm.v201erratum4. Erratum in: Am J Respir Crit Care Med. 2020 Jun 1;201(11):1454. doi: 10.1164/rccm.v201erratum5. PMID: 30372119.
9. Jernigan JA, Hatfield KM, Wolford H, Nelson RE, Olubajo B, Reddy SC, McCarthy N, Paul P, McDonald LC, Kallen A, Fiore A, Craig M, Baggs J. Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017. N Engl J Med. 2020 Apr 2;382(14):1309-1319. doi: 10.1056/NEJMoa1914433. PMID: 32242356; PMCID: PMC10961699.
10. Timsit JF, Baleine J, Bernard L, Calvino-Gunther S, Darmon M et al., Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit. Ann Intensive Care. 2020 Sep 7;10(1):118. doi: 10.1186/s13613-020-00713-4. PMID: 32894389; PMCID: PMC7477021.
11. Nelson GE, Narayanan N, Onguti S, Stanley K, Newland JG, Doernberg SB. Principles and Practice of Antimicrobial Stewardship Program Resource Allocation. Infect Dis Clin North Am. 2023 Dec;37(4):683-714. doi: 10.1016/j.idc.2023.07.002. PMID: 37735012.
12. Zaragoza R, Vidal-Cortés P, Aguilar G, Borges M, Diaz E, Ferrer R, Maseda E, Nieto M, Nuvials FX, Ramirez P, Rodriguez A, Soriano C, Veganzones J, Martín-Loeches I. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care. 2020 Jun 29;24(1):383. doi: 10.1186/s13054-020-03091-2. PMID: 32600375; PMCID: PMC7322703.
13. Choi MH, Kim D, Lee KH, Cho JH, Jeong SH. Changes in the prevalence of pathogens causing hospital-acquired bacterial pneumonia and the impact of their antimicrobial resistance patterns on clinical outcomes: A propensity-score-matched study. Int J Antimicrob Agents. 2023 Sep;62(3):106886. doi: 10.1016/j.ijantimicag.2023.106886. Epub 2023 Jun 19. PMID: 37343808.
14. Bateman RM, Sharpe MD, Jagger JE et al., 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Erratum in: Crit Care. 2016 Oct 24;20:347. doi: 10.1186/s13054-016-1358-6. PMID: 27885969; PMCID: PMC5493079.
15. Tabah A, Buetti N, Staiquly Q, Ruckly S et al., EUROBACT-2 Study Group, ESICM, ESCMID ESGCIP and the OUTCOMEREA Network. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med. 2023 Feb;49(2):178-190. doi: 10.1007/s00134-022-06944-2. PMID: 36764959; PMCID: PMC9916499.
16. Chen WC, Hung CH, Chen YS, Cheng JS, Lee SS, Tseng FC, Cheng MF, Wang JL. Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Patients with Liver Cirrhosis. Pathogens. 2021 Jan 5;10(1):37. doi: 10.3390/pathogens10010037. PMID: 33466521; PMCID: PMC7824895.
17. Prabaker K, Weinstein RA. Trends in antimicrobial resistance in intensive care units in the United States. Curr Opin Crit Care. 2011 Oct;17(5):472-9. doi: 10.1097/MCC.0b013e32834a4b03. PMID: 21900766.
18. Mohammed R, Nader SM, Hamza DA, Sabry MA. Occurrence of carbapenem-resistant hypervirulent Klebsiella pneumoniae in oysters in Egypt: a significant public health issue. Ann Clin Microbiol Antimicrob. 2024 Jun 17;23(1):53. doi: 10.1186/s12941-024-00711-5. PMID: 38886796; PMCID: PMC11184735.
19. Giamarellou H, Galani L, Karavasilis T, Ioannidis K, Karaiskos I. Antimicrobial Stewardship in the Hospital Setting: A Narrative Review. Antibiotics (Basel). 2023 Oct 21;12(10):1557. doi: 10.3390/antibiotics12101557. PMID: 37887258; PMCID: PMC10604258.
20. Radera S, Srivastava S, Agarwal J. Virulence Genotyping and Multidrug Resistance Pattern of Escherichia coli Isolated From Community-Acquired and Hospital-Acquired Urinary Tract Infections. Cureus. 2022 Sep 21;14(9):e29404. doi: 10.7759/cureus.29404. PMID: 36304345; PMCID: PMC9586185.
21. Karamolahi S, Kaviar VH, Haddadi MH, Hashemian M, Feizi J, Sadeghifard N, Khoshnood S. Molecular characterization of Staphylococcus aureus isolated from hospital-acquired infections in Ilam, Iran. Mol Biol Rep. 2024 May 25;51(1):686. doi: 10.1007/s11033-024-09580-9. PMID: 38796602.
22. Basnet A, Joshi P, Shrestha SKD, Khanal LK, Karmacharya M, Shrestha S, Rai SK. Antimicrobial Resistance in Bacterial Species Causing Orthopaedic Surgical Site Infections at a National Trauma Center, Kathmandu, Nepal. Am J Trop Med Hyg. 2024 Sep 18;111(6):1237-1242. doi: 10.4269/ajtmh.24-0038. PMID: 39293406; PMCID: PMC11619503.
23. Della Rocca MT, Foglia F, Crudele V, Greco G, De Filippis A, Franci G, Finamore E, Galdiero M. Antimicrobial resistance changing trends of Klebsiella pneumoniae isolated over the last 5 years. New Microbiol. 2022 Dec;45(4):338-343. PMID: 36538299.
24. Motsch J, Murta de Oliveira C, Stus V et al., Paschke A. RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections. Clin Infect Dis. 2020 Apr 15;70(9):1799-1808. doi: 10.1093/cid/ciz530. PMID: 31400759; PMCID: PMC7156774.
25. Saleem M, Moursi SA, Altamimi TNA, Salem AM, Alaskar AM, Hammam SAH, Rakha E, Ilyas SMO, Al-Malaq HA, Alshammari MN, Syed Khaja AS. Identifying multidrug-resistant organisms in diabetic foot ulcers: a study of risk factors and antimicrobial resistance genes. World J Microbiol Biotechnol. 2024 Dec 18;41(1):3. doi: 10.1007/s11274-024-04209-2. PMID: 39690319.
26. Carrara E, Conti M, Meschiari M, Mussini C. The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2021 Jan 29;76(Suppl 1):i12-i18. doi: 10.1093/jac/dkaa493. PMID: 33534879.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhammad Saiful Hasan, Abul Bashar, Syeda Anjuman Nasreen (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
